Resistance training performance.
Conditions
Interventions
Intervention 1: The first intervention group: supplementation with L-citrulline (8 grams of L-citrulline + 15 grams of maltodextrin) 60 minutes before the start of each main research session (resistan
in the acute phase, a single dose session and in the chronic phase, daily for eight weeks. Intervention 3: Control group: The third group: supplementation with a placebo (15 grams of maltodextrin) 60
in the acute phase, a single dose session and in the chronic phase, daily for eight weeks.
Sponsors
Razi university
Eligibility
Sex/Gender
Male
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Healthy men living in Kermanshah with an age range between 18 and 35 years History of resistance training at least 3 sessions per week in the last six months Body mass index 18.5 to 29.99 (kg/m2)
Exclusion criteria
Exclusion criteria: Smoking Current or past use of anabolic androgenic steroids Consuming performance-enhancing supplements affecting the research results (including creatine, HMB, beta-alanine and NO stimulants) in the four weeks leading up to the start of the research, or taking L-citrulline or citrulline malate supplements in the past year Suffering from musculoskeletal injuries affecting the process of performing resistance training exercises Having any acute or chronic disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resistance training performance. Timepoint: Acute phase: three acute research sessions with an interval of one week from each other. Chronic phase: one research session before and one session at the end of the eight-week protocol. Method of measurement: Recording the number of repetitions performed in each set of resistance training - recording the rate of perceived exertion using the Borg scale - measuring muscle soreness using a Visual Analog Scale (VAS) questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood factors (Lactate and Nitric Oxide). Timepoint: Acute phase: three acute research sessions with an interval of one week from each other. Chronic phase: one research session before and one session at the end of the eight-week protocol. Method of measurement: Blood sampling from each subject before and after each main research session. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDavoud Bayat
Razi university
Outcome results
None listed